# Ibuprofen/Caffeine Lower Back or Neck Pain Study

> **NCT03003000** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 635 (actual)

## Conditions studied

- Back Pain
- Neck Pain

## Interventions

- **DRUG:** ibuprofen
- **DRUG:** caffeine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03003000
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-20
- **Primary completion:** 2017-09-24
- **Final completion:** 2017-09-28
- **Target enrollment:** 635 (ACTUAL)
- **Last updated:** 2019-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03003000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03003000, "Ibuprofen/Caffeine Lower Back or Neck Pain Study". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03003000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*